Press Releases
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new facility at its Copenhagen, Denmark site....
News
Clinerion patent for technology underpinning Patient Network Explorer is published
The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as...
Press Releases
Zydus receives EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world
Zydus Cadila announced that the company has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the...
Drug Research
Zydus partners with CHEMI of Italy to launch Enoxaparin Sodium Injection in the United States
Zydus Pharmaceuticals Inc, USA (a 100% subsidiary of Cadila Healthcare Limited (Zydus Cadila), a leading innovation-driven, global healthcare provider, has signed a license and...
Drug Research
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies
CM Life Sciences II and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation, a company enabling customers to succeed...
Clinical Trials
Curevac’s CV2CoV Demonstrates Improved Immune Response And Protection In Preclinical Study
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, and GSK announced the publication of...
Drug Research
Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine Program Against SARS-CoV-2 Variants of Concern
Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the company entered into a funding agreement...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read